ASST Papa Giovanni XXIII at ISLB 2026

Nov 7–9, 2026 Madrid, Spain ~700 attendees Website

ASST Papa Giovanni XXIII brings 2 presentations to ISLB 2026 in Madrid. Its work centres on methylation patterns in cell-free DNA for cancer detection and monitoring. One study tracks tumour DNA methylation over time to follow treatment response and persistent disease in peripheral T-cell lymphoma, and another separates breast cancer cases from healthy controls.

OrganizationISLB 2026 Attendance
Hospitals & cancer centres
Public hospital trust in Bergamo running the Papa Giovanni XXIII hospital.
Poster
Targeted Cell-free DNA Methylation Profiling Discriminates Breast-cancer Cases from Healthy Controls and Tracks Clinical and Molecular Features
Early detection · ctDNA & MRD
Collaborators: Humanitas Research Hospital

Explore the full ISLB 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ISLB 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from ASST Papa Giovanni XXIII

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the International Society of Liquid Biopsy (ISLB). Submit a correction